...
首页> 外文期刊>Phytotherapy research: PTR >Total alkaloids of sophorea alopecuroides-induced down-regulation of acrab-tolc efflux pump reverses susceptibility to ciprofloxacin in clinical multidrug resistant escherichia coli isolates
【24h】

Total alkaloids of sophorea alopecuroides-induced down-regulation of acrab-tolc efflux pump reverses susceptibility to ciprofloxacin in clinical multidrug resistant escherichia coli isolates

机译:Sophorea Alopecuroides诱导的Acrab-tolc外排泵下调的总生物碱逆转了临床多重耐药性大肠杆菌分离物中对环丙沙星的敏感性

获取原文
获取原文并翻译 | 示例
           

摘要

In this report, total alkaloids extracted from the seeds of Sophorea alopecuroides (TASA) was evaluated against clinical Escherichia coli isolates resistant to four tested antibiotics, ampicillin (AM), amikacin (AN), cefotaxime (CTX) and ciprofloxacin (CIP). The TASA showed an antibacterial activity against the multidrug resistant (MDR) isolates. In combination with TASA, synergistic effects on the tested antibiotics against the MRD isolates were observed. Similarly, the isolates pretreated with a lower dose of TASA yielded increased and stable susceptibilities to CIP by 16-32-fold determined by a microbroth dilution checkerboard method. Moreover, quantitative reverse transcription-polymerase chain reaction (qRT-PCR) analysis revealed a constitutive overexpression of the AcrAB-TolC pump system in the tested MDR isolates. The pretreatment of MDR isolates with TASA resulted in a statistically down-regulated expression of acrA and acrB genes, and an up-regulated expression of acrR gene (p < 0.05). But the expression of tolC gene was not significantly altered (p > 0.05). These results suggested that the TASA-induced reversal resistance to CIP might be partially through a mechanism of inhibition of the AcrAB-TolC pump activity in these isolates, implying that the TASA can be used as a potential natural source to develop efflux pump inhibitors (EPI) against AcrAB-TolC pump mediated MDR in E. coli isolates.
机译:在本报告中,对从Sophorea alopecuroides(TASA)种子中提取的总生物碱进行了针对临床大肠杆菌分离株的评估,这些分离株对四种测试的抗生素,氨苄青霉素(AM),阿米卡星(AN),头孢噻肟(CTX)和环丙沙星(CIP)具有抗性。 TASA对多药耐药性(MDR)分离物表现出抗菌活性。与TASA联合使用时,观察到了针对MRD分离物的测试抗生素的协同作用。同样,用微剂量稀释棋盘法测定,用较低剂量的TASA预处理的分离株对CIP的敏感性提高了16-32倍。此外,定量逆转录-聚合酶链反应(qRT-PCR)分析表明,在测试的MDR分离物中AcrAB-TolC泵系统组成性过表达。用TASA预处理MDR分离物会导致acrA和acrB基因的表达在统计学上下调,而acrR基因的表达上调(p <0.05)。但是,tolC基因的表达没有明显改变(p> 0.05)。这些结果表明,TASA诱导的对CIP的逆转耐药性可能部分是通过抑制这些菌株中AcrAB-TolC泵活性的机制实现的,这意味着TASA可用作开发外排泵抑制剂(EPI)的潜在天然来源。 )针对大肠杆菌分离物中AcrAB-TolC泵介导的MDR。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号